Neoprobe Corporation to Present at Biotechnology Industry Organization (BIO) CEO Conference

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present on Monday, February 9, 2009 at 2:15PM EST, during the 11th Annual BIO CEO & Investor Conference to be held at the Waldorf Astoria Hotel in New York, NY.

MORE ON THIS TOPIC